Life-threatening diseases are increasing among the population, requiring constant medical support through surgeries. Despite the rising preference for minimally invasive treatments, the focus on reducing patients' blood loss drives the demand for hemostasis products. , /PRNewswire/ -- The progress of the is attributed to various drivers that will elevate the size of the industry from , measured in 2023, to by 2034.
Owing to multiple trends and market drivers, the progress of the competitive landscape is estimated to traverse a moderate advancement path, projecting a through the forecasted period. With the growing number of accidental cases, the number of surgeries required is proliferating. Due to this rising number, the demand for hemostasis products is expected to increase, which will likely drive the global landscape.
The rising number of chronic diseases is expected to fuel the demand for surgical interventions. This will fuel the demand for hemostasis products to reduce blood loss during surgeries. Orthopedic disorders are expected to drive the momentum toward the global hemostasis products realm.
With the rising demand in new and emerging sectors, such products will cover a wider spectrum, creating prospects for key players. The elevation of safety features and rising precision in drug delivery systems will likely augment products in the industry. The growing field of biotechnology will also help the proliferation of the products portfolio, driving the demand for the se.
